News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
869,508 Results
Type
Article (87927)
Company Profile (825)
Press Release (780740)
Multimedia
Podcasts (193)
Webinars (28)
Section
Business (233249)
Career Advice (4146)
Deals (39872)
Drug Delivery (148)
Drug Development (91405)
Employer Resources (204)
FDA (18380)
Job Trends (17424)
News (397877)
Policy (39962)
Tag
Academia (3010)
Academic (2)
Accelerated approval (33)
Adcomms (36)
Allergies (144)
Alliances (56981)
ALS (180)
Alzheimer's disease (1785)
Antibody-drug conjugate (ADC) (338)
Approvals (18553)
Artificial intelligence (616)
Autoimmune disease (155)
Automation (35)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (199)
Biotechnology (490)
Bladder cancer (161)
Brain cancer (65)
Breast cancer (650)
Cancer (4959)
Cardiovascular disease (437)
Career advice (3569)
Career pathing (41)
CAR-T (302)
CDC (59)
Celiac Disease (1)
Cell therapy (819)
Cervical cancer (37)
Clinical research (76929)
Collaboration (1767)
Company closure (5)
Compensation (1138)
Complete response letters (70)
COVID-19 (2989)
CRISPR (97)
C-suite (836)
Cystic fibrosis (154)
Data (6177)
Decentralized trials (2)
Denatured (70)
Depression (149)
Diabetes (528)
Diagnostics (7214)
Digital health (44)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (298)
Drug pricing (221)
Drug shortages (36)
Duchenne muscular dystrophy (234)
Earnings (100057)
Editorial (62)
Employer branding (25)
Employer resources (173)
Events (134993)
Executive appointments (1027)
FDA (21488)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1535)
Gene editing (211)
Generative AI (63)
Gene therapy (662)
GLP-1 (1111)
Government (5434)
Grass and pollen (8)
Guidances (383)
Healthcare (20942)
HIV (60)
Huntington's disease (48)
IgA nephropathy (86)
Immunology and inflammation (287)
Immuno-oncology (56)
Indications (85)
Infectious disease (3274)
Inflammatory bowel disease (203)
Inflation Reduction Act (17)
Influenza (118)
Intellectual property (242)
Interviews (816)
IPO (17954)
IRA (60)
Job creations (5199)
Job search strategy (2866)
Kidney cancer (17)
Labor market (90)
Layoffs (658)
Leadership (40)
Legal (10158)
Liver cancer (98)
Longevity (14)
Lung cancer (676)
Lymphoma (374)
Machine learning (44)
Management (66)
Manufacturing (826)
MASH (172)
Medical device (15009)
Medtech (15054)
Mergers & acquisitions (22963)
Metabolic disorders (1375)
Multiple sclerosis (159)
NASH (23)
Neurodegenerative disease (346)
Neuropsychiatric disorders (93)
Neuroscience (3080)
NextGen: Class of 2026 (7707)
Non-profit (5110)
Now hiring (63)
Obesity (662)
Opinion (332)
Ovarian cancer (164)
Pain (200)
Pancreatic cancer (227)
Parkinson's disease (291)
Partnered (39)
Patents (494)
Patient recruitment (462)
Peanut (60)
People (66837)
Pharmaceutical (145)
Pharmacy benefit managers (32)
Phase I (23776)
Phase II (33376)
Phase III (25163)
Pipeline (4778)
Policy (330)
Postmarket research (3554)
Preclinical (10687)
Press Release (72)
Prostate cancer (241)
Psychedelics (53)
Radiopharmaceuticals (298)
Rare diseases (876)
Real estate (7438)
Recruiting (80)
Regulatory (28910)
Reports (66)
Research institute (2722)
Resumes & cover letters (651)
Rett syndrome (27)
RNA editing (20)
RSV (83)
Schizophrenia (157)
Series A (255)
Series B (193)
Service/supplier (30)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (176)
Sponsored (48)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (112)
Tariffs (98)
The Weekly (121)
Vaccines (1134)
Venture capital (92)
Weight loss (457)
Women's health (85)
Worklife (21)
Date
Today (110)
Last 7 days (400)
Last 30 days (2096)
Last 365 days (33239)
2026 (1821)
2025 (33226)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (88)
Alaska (7)
Arizona (340)
Arkansas (14)
Asia (51514)
Australia (9042)
California (11378)
Canada (3280)
China (1144)
Colorado (483)
Connecticut (496)
Delaware (342)
Europe (118343)
Florida (1661)
Georgia (366)
Hawaii (3)
Idaho (68)
Illinois (949)
India (66)
Indiana (537)
Iowa (24)
Japan (416)
Kansas (133)
Kentucky (42)
Louisiana (29)
Maine (83)
Maryland (1444)
Massachusetts (8410)
Michigan (353)
Minnesota (656)
Mississippi (6)
Missouri (139)
Montana (35)
Nebraska (29)
Nevada (123)
New Hampshire (85)
New Jersey (3076)
New Mexico (33)
New York (3013)
North Carolina (1592)
North Dakota (10)
Northern California (5427)
Ohio (349)
Oklahoma (22)
Oregon (54)
Pennsylvania (2280)
Puerto Rico (21)
Rhode Island (50)
South America (1657)
South Carolina (63)
South Dakota (1)
Southern California (4387)
Tennessee (174)
Texas (1797)
United States (41153)
Utah (341)
Vermont (1)
Virginia (285)
Washington D.C. (86)
Washington State (957)
West Virginia (4)
Wisconsin (123)
Wyoming (2)
There are 869,508 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
C-suite
JPM26: Filling C-Suites, Union Square—And Elevators—With Pink
Attendance at the Biotech CEO Sisterhood’s annual photo of women leaders and allies in Union Square doubled this year. There’s still more work to do.
January 21, 2026
·
2 min read
·
Annalee Armstrong
Business
JPM26: KalVista’s HAE Win Is a ‘Tale of Two Markets’
After winning a surprise approval for its hereditary angioedema drug Ekterly, KalVista is confident the oral offering will capture the lion’s share of the market for on-demand use.
January 21, 2026
·
3 min read
·
Dan Samorodnitsky
Press Releases
IntraBio Receives European Commission Approval of AQNEURSA® for the Treatment of Niemann-Pick Type C Disease
January 21, 2026
·
7 min read
Press Releases
IntraBio Announces Positive Pivotal Trial Results of Levacetylleucine for the Treatment of Ataxia-Telangiectasia
January 21, 2026
·
5 min read
Press Releases
Truvian Health Receives another FDA Clearance – for Complete Blood Count (CBC) on TruVerus™
January 21, 2026
·
4 min read
Press Releases
Charles River Enters Manufacturing Collaboration with Gazi University
January 21, 2026
·
2 min read
Press Releases
Odyssey Therapeutics Appoints Jolie M. Siegel as Executive Vice President, General Counsel
January 21, 2026
·
3 min read
Press Releases
U.S. FDA Grants to Wugen’s WU-CART-007 Breakthrough Therapy Designation for Treatment of Relapsed or Refractory T Cell Acute Lymphoblastic Leukemia / T Cell Lymphoblastic Lymphoma
January 21, 2026
·
4 min read
Press Releases
Soley Therapeutics Announces Breakthrough Research Demonstrating How Cellular Stress Responses Reveal Drug Mechanisms, Enabling Entirely New and Accelerated Methods for Drug Discovery
January 21, 2026
·
3 min read
Press Releases
Agenus Expands Medical Affairs Infrastructure to Support Increasing Physician Requests for Authorized Access to Botensilimab Plus Balstilimab
January 21, 2026
·
8 min read
1 of 86,951
Next
